Literature DB >> 29236223

Transit and lifespan in neutrophil production: implications for drug intervention.

Daniel Câmara De Souza1, Morgan Craig2, Tyler Cassidy1, Jun Li3, Fahima Nekka3, Jacques Bélair4, Antony R Humphries5.   

Abstract

A comparison of the transit compartment ordinary differential equation modelling approach to distributed and discrete delay differential equation models is studied by focusing on Quartino's extension to the Friberg transit compartment model of myelosuppression, widely relied upon in the pharmaceutical sciences to predict the neutrophil response after chemotherapy, and on a QSP delay differential equation model of granulopoiesis. An extension to the Quartino model is provided by considering a general number of transit compartments and introducing an extra parameter that allows for the decoupling of the maturation time from the production rate of cells. An overview of the well established linear chain technique, used to reformulate transit compartment models with constant transit rates as distributed delay differential equations (DDEs), is then given. A state-dependent time rescaling of the Quartino model is performed to apply the linear chain technique and rewrite the Quartino model as a distributed DDE, yielding a discrete DDE model in a certain parameter limit. Next, stability and bifurcation analyses are undertaken in an effort to situate such studies in a mathematical pharmacology context. We show that both the original Friberg and the Quartino extension models incorrectly define the mean maturation time, essentially treating the proliferative pool as an additional maturation compartment. This misspecification can have far reaching consequences on the development of future models of myelosuppression in PK/PD.

Entities:  

Keywords:  Bifurcation analyses; Delay differential equations; Granulopoiesis; Linear chain technique; Mathematical pharmacology; Transit compartment models

Mesh:

Substances:

Year:  2017        PMID: 29236223     DOI: 10.1007/s10928-017-9560-y

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  32 in total

Review 1.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

Authors:  B Agoram; W S Woltosz; M B Bolger
Journal:  Adv Drug Deliv Rev       Date:  2001-10-01       Impact factor: 15.470

2.  Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay.

Authors:  Narendra M Dixit; Alan S Perelson
Journal:  J Theor Biol       Date:  2004-01-07       Impact factor: 2.691

Review 3.  Mechanistic models for myelosuppression.

Authors:  Lena E Friberg; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

4.  Model of chemotherapy-induced myelosuppression with parameter consistency across drugs.

Authors:  Lena E Friberg; Anja Henningsson; Hugo Maas; Laurent Nguyen; Mats O Karlsson
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

5.  A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.

Authors:  J L Steimer; Y Plusquellec; A Guillaume; J F Boisvieux
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

6.  Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

Authors:  C N Sternberg; P de Mulder; J H Schornagel; C Theodore; S D Fossa; A T van Oosterom; J A Witjes; M Spina; C J van Groeningen; B Duclos; J T Roberts; C de Balincourt; L Collette
Journal:  Eur J Cancer       Date:  2005-12-05       Impact factor: 9.162

Review 7.  Regulation of neutrophil homeostasis.

Authors:  Matthew J Christopher; Daniel C Link
Journal:  Curr Opin Hematol       Date:  2007-01       Impact factor: 3.284

8.  Cyclical neutropenia and the peripheral control of white blood cell production.

Authors:  T Hearn; C Haurie; M C Mackey
Journal:  J Theor Biol       Date:  1998-05-21       Impact factor: 2.691

9.  Mathematical model for G-CSF administration after chemotherapy.

Authors:  Catherine Foley; Michael C Mackey
Journal:  J Theor Biol       Date:  2008-11-01       Impact factor: 2.691

Review 10.  Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.

Authors:  M Craig
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-04-18
View more
  8 in total

1.  Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-07-09       Impact factor: 2.745

2.  Ordinary differential equation approximation of gamma distributed delay model.

Authors:  Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-07       Impact factor: 2.745

3.  A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim.

Authors:  Ari Brekkan; Luis Lopez-Lazaro; Gunnar Yngman; Elodie L Plan; Chayan Acharya; Andrew C Hooker; Suresh Kankanwadi; Mats O Karlsson
Journal:  AAPS J       Date:  2018-08-15       Impact factor: 4.009

4.  Generalizations of the 'Linear Chain Trick': incorporating more flexible dwell time distributions into mean field ODE models.

Authors:  Paul J Hurtado; Adam S Kirosingh
Journal:  J Math Biol       Date:  2019-08-13       Impact factor: 2.259

Review 5.  Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Authors:  Carmen Pin; Teresa Collins; Megan Gibbs; Holly Kimko
Journal:  AAPS J       Date:  2021-05-20       Impact factor: 4.009

6.  Importance of Stability Analysis When Using Nonlinear Semimechanistic Models to Describe Drug-Induced Hematotoxicity.

Authors:  Chiara Fornari; Carmen Pin; James W T Yates; Jerome T Mettetal; Teresa A Collins
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-07-08

7.  A simple model of COVID-19 explains disease severity and the effect of treatments.

Authors:  Steven Sanche; Tyler Cassidy; Pinghan Chu; Alan S Perelson; Ruy M Ribeiro; Ruian Ke
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

8.  Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model.

Authors:  Chiara Fornari; Lenka Oplustil O'Connor; Carmen Pin; Aaron Smith; James W T Yates; S Y Amy Cheung; Duncan I Jodrell; Jerome T Mettetal; Teresa A Collins
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.